PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50125F61012 — TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS

TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS is a federal award for Department of Health and Human Services (HHS) held by SANOFI PASTEUR INC.. Estimated value $24.9M ($24.9M obligated). Current period of performance ends Sep 4, 2028. Place of performance: SWIFTWATER PA. Related solicitation RTOR #: 2025-00015.

$24.9M
Estimated Value
Sep 4, 2028
PoP End / Expires

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

SANOFI PASTEUR INC. holds $3.7B across 396 federal awards, concentrated at Department of Health and Human Services (HHS). Recompete timing centers on the Sep 4, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract number75A50125F61012
AgencyDepartment of Health and Human Services (HHS)
IncumbentSANOFI PASTEUR INC.
CAGE7V915
UEINCXBGGQ8YTU9
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12
Parent IDIQ / IDV75A50122D00003
Place of performanceSWIFTWATER PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationRTOR #: 2025-00015
PoP startSep 5, 2025
PoP end (current)Sep 4, 2028
Obligated$24.9M
Current value$24.9M
Potential value$24.9M

TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS

Recompete timing

Public
Expiring in 749 days

Current PoP ends Sep 4, 2028 (749 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 4, 2027.

Watch this contract — one email →

Incumbent footprint

Public record

SANOFI PASTEUR INC.$3.7B obligated across 396 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.7B) · all agencies · Top 4 shown (98%); remaining ~2% is other agencies.
Department of Health and Human Services (HHS)$3.6B · 97%Department of Defense (DOD)$29.1M · 1%Department of Veterans Affairs (VA)$6.9M · 0%
Department of State (DOS)$2.4M · 0%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open SANOFI PASTEUR INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50125F61012?

75A50125F61012 (TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS) is a Department of Health and Human Services (HHS) award with an estimated value of $24.9M, currently held by SANOFI PASTEUR INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50125F61012?

SANOFI PASTEUR INC. is the incumbent with $3.7B across 396 related awards in SCOUT’s public footprint. The current period of performance ends Sep 4, 2028.

When does 75A50125F61012 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 4, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50122D00003-75A50125F61012